Low-dose nivolumab induced durable complete response in relapsed primary central nervous system diffuse large B cell lymphoma

Ann Hematol. 2019 Sep;98(9):2227-2230. doi: 10.1007/s00277-019-03758-z. Epub 2019 Jul 26.

Authors

Thomas S Y Chan¹, Pek-Lan Khong², Rex Au-Yeung³, Yok-Lam Kwong⁴, Eric Tse¹

Affiliations

¹ Department of Medicine, Queen Mary Hospital, Pokfulm Road, Hong Kong, China.
² Department of Diagnostic Radiology, Queen Mary Hospital, Hong Kong, Hong Kong.
³ Department of Pathology, Queen Mary Hospital, Hong Kong, Hong Kong.
⁴ Department of Medicine, Queen Mary Hospital, Pokfulm Road, Hong Kong, China. [email protected].

PMID: 31346688
DOI: 10.1007/s00277-019-03758-z

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Brain Neoplasms / diagnostic imaging
Brain Neoplasms / drug therapy*
Brain Neoplasms / metabolism
Brain Neoplasms / pathology
Humans
Lymphoma, Large B-Cell, Diffuse / diagnostic imaging
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Lymphoma, Large B-Cell, Diffuse / metabolism
Lymphoma, Large B-Cell, Diffuse / pathology
Magnetic Resonance Imaging
Male
Nivolumab / administration & dosage*

Substances

Nivolumab